Search Results - "Lu, Lily D"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
  2. 2
  3. 3

    Therapeutic efficacy of CEP-33779, a novel selective JAK2 inhibitor, in a mouse model of colitis-induced colorectal cancer by Seavey, Matthew M, Lu, Lily D, Stump, Kristine L, Wallace, Nate H, Hockeimer, William, O'Kane, Teresa M, Ruggeri, Bruce A, Dobrzanski, Pawel

    Published in Molecular cancer therapeutics (01-04-2012)
    “…Constitutively activated STAT3 and STAT5 are expressed in a wide variety of human malignancies including solid and hematopoietic cancers and often correlate…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The In-Cell Western immunofluorescence assay to monitor PROTAC mediated protein degradation by Lu, Lily D, Salvino, Joseph M

    Published in Methods in enzymology (01-01-2023)
    “…The In-Cell Western plate-based immunofluorescence assay is a useful methodology for monitoring protein levels and provides a facile moderate through-put…”
    Get more information
    Journal Article
  6. 6

    Novel, orally active, proteasome inhibitor, delanzomib (CEP-18770), ameliorates disease symptoms and glomerulonephritis in two preclinical mouse models of SLE by Seavey, Matthew M., Lu, Lily D., Stump, Kristine L., Wallace, Nate H., Ruggeri, Bruce A.

    Published in International immunopharmacology (2012)
    “…Current therapies for late-stage systemic lupus erythematosus (SLE) are limited to cytotoxic agents. Delanzomib (CEP-18770) is an orally active, reversible P2…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Chemical-inducible, ecdysone receptor-based gene expression system for plants by PADIDAM, Malla, GORE, Michael, LU, D. Lily, SMIRNOVA, Olga

    Published in Transgenic research (01-02-2003)
    “…We have developed an inducible gene expression system with potential for field application using the ecdysone receptor (EcR) from the spruce budworm and the…”
    Get full text
    Journal Article
  9. 9

    Novel method of monitoring trace cytokines and activated STAT molecules in the paws of arthritic mice using multiplex bead technology by Lu, Lily D, Stump, Kristine L, Seavey, Matthew M

    Published in BMC immunology (12-11-2010)
    “…The use of mouse models to study human disease provides useful data that can provide support for research projects or an existing drug discovery program. How…”
    Get full text
    Journal Article
  10. 10

    Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities by SCHAFFHAUSER, Hervé, MATHIASEN, Joanne R, DICAMILLO, Amy, HUFFMAN, Mark J, LU, Lily D, MCKENNA, Beth A, JIE QIAN, MARINO, Michael J

    Published in Biochemical pharmacology (15-10-2009)
    “…Dimebolin (Dimebon), is a non-selective antihistamine approved in Russia for the treatment of allergy. Recently, this drug has been shown to be neuroprotective…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Animal models of systemic lupus erythematosus (SLE) and ex vivo assay design for drug discovery by Seavey, Matthew M, Lu, Lily D, Stump, Kristine L

    Published in Current protocols in pharmacology (01-06-2011)
    “…Systemic Lupus Erythematosus (SLE) is a debilitating and often fatal autoimmune disease that involves multiple organ systems. It can develop for years before…”
    Get more information
    Journal Article
  13. 13

    Dimebolin is a 5-HT sub(6) antagonist with acute cognition enhancing activities by Schaffhauser, Herve, Mathiasen, Joanne R, DiCamillo, Amy, Huffman, Mark J, Lu, Lily D, McKenna, Beth A, Qian, Jie, Marino, Michael J

    Published in Biochemical pharmacology (15-10-2009)
    “…Dimebolin (Dimebon[TM]), is a non-selective antihistamine approved in Russia for the treatment of allergy. Recently, this drug has been shown to be…”
    Get full text
    Journal Article
  14. 14

    Dimebolin is a 5-HT 6 antagonist with acute cognition enhancing activities by Schaffhauser, Hervé, Mathiasen, Joanne R., DiCamillo, Amy, Huffman, Mark J., Lu, Lily D., McKenna, Beth A., Qian, Jie, Marino, Michael J.

    Published in Biochemical pharmacology (2009)
    “…Dimebolin (Dimebon™), is a non-selective antihistamine approved in Russia for the treatment of allergy. Recently, this drug has been shown to be…”
    Get full text
    Journal Article